Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 6 (2) , 83-88
- https://doi.org/10.1007/bf00255578
Abstract
Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions. Since it is eliminated mainly in the urine, the drug accumulates in patients with uraemia. The excretion of tranexamic acid in patients with renal failure has been investigated and dosage recommendations are given for tranexamic acid therapy in cases of renal failure.Keywords
This publication has 10 references indexed in Scilit:
- TRAUMATIC HYPHAEMA TREATED WITH THE ANTIFIBRINOLYTIC DRUG TRANEXAMIC ACIDActa Ophthalmologica, 2009
- TRANEXAMIC ACID (AMCA) AND LATE HYPHAEMAActa Ophthalmologica, 1976
- Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteersEuropean Journal of Clinical Pharmacology, 1974
- The Effect of Tranexamic Acid (Amca) On Postoperative Bleeding After ConizationActa Obstetricia et Gynecologica Scandinavica, 1972
- Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.1970
- Antifibrinolytic treatment with tranexamic acid (AMCA) in pediatric urinary tract surgeryJournal of Pediatric Surgery, 1970
- Amca (Aminomethyl Cyclohexane Carboxylic Acid, Cyklo-Kapron®) a Potent Haemostatic Agent in Urinary Tract BleedingScandinavian Journal of Urology and Nephrology, 1969
- Antifibrinolytic Therapy with Cyklokapron in Connection with Prostatectomy: A Double Blind StudyScandinavian Journal of Urology and Nephrology, 1969
- ROLE OF UROKINASE AND TISSUE ACTIVATOR IN SUSTAINING BLEEDING AND THE MANAGEMENT THEREOF WITH EACA AND AMCAAnnals of the New York Academy of Sciences, 1968
- Plasminogen Activators in the EndometriumActa Obstetricia et Gynecologica Scandinavica, 1966